MIR SCIENTIFIC

History

YearDetail
2013 Founded in 2013 and headquartered in New York, miR Scientific is a precision healthcare company that aims to improve public health by transforming cancer management globally.
2022 The company commercially launched the miR Sentinel Prostate Cancer Test in the U.S., Puerto Rico, and select international markets. It is a novel, urine-based molecular test that analyzes small non-coding RNA using a proprietary biostatistical algorithm.
AI Sentiment